🔎 Trials Near Me

Pradžia › Melanoma › Washington › Seattle

Melanoma klinikiniai tyrimai Seattle, WA

17 tyrimai dėl Melanoma ieško dalyvių vietose Seattle ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
  • ir dar 1
Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05334069

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

Renkami dalyviai2 fazė
  • Fred Hutchinson Cancer Center ( Site 4041), Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06961006

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Renkami dalyviai3 fazė
  • Swedish Cancer Institute, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06246916

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Renkami dalyviai3 fazė
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center - Montlake, Seattle
  • Saint Joseph Medical Center Hematology and Oncology - Silverdale, Silverdale · už 17 mylių
Amžius 75 ir vyresni · Visoms lytims · Atnaujinta 2026-09-24 · NCT07068074

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Renkami dalyviai1/2 fazė
  • University of Washington Fred Hutchinson Cancer Center, Seattle
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT06814496

A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)

Renkami dalyviai2 fazė
  • Local Institution - 0086, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07492680

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Renkami dalyviai2 fazė
  • Swedish Medical Center-Ballard Campus, Seattle
  • Swedish Medical Center-Cherry Hill, Seattle
  • Swedish Medical Center-First Hill, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-15 · NCT04511013

Project: Every Child for Younger Patients With Cancer

Renkami dalyviaiStebimasis tyrimas
  • Seattle Children's Hospital, Seattle
Iki 25 metų · Visoms lytims · Atnaujinta 2026-08-25 · NCT02402244

High-Intensity Exercise and High-Fiber Diet for Immunotherapy Outcomes in Melanoma Patients: The DUO Trial

Renkami dalyviai
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT06298734

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

Renkami dalyviai1 fazė
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-22 · NCT05098210

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Renkami dalyviai1/2 fazė
  • Virginia Mason Medical Center, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-15 · NCT05379985

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Renkami dalyviai1/2 fazė
  • Fred Hutchinson Cancer Center, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-05-13 · NCT03686124

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Renkami dalyviai2/3 fazė
  • Fred Hutchinson Cancer Center, Seattle
Visi amžiai · Visoms lytims · Atnaujinta 2026-04-02 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Renkami dalyviaiStebimasis tyrimas
  • Kaiser Permanente Washington, Seattle
  • Swedish Medical Center-First Hill, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-03-17 · NCT06418204

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Renkami dalyviai3 fazė
  • Fred Hutchinson Cancer Center, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-25 · NCT05549297

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Renkami dalyviaiStebimasis tyrimas
  • Massive Bio SYNERGY-AI site, Seattle
Visi amžiai · Visoms lytims · Atnaujinta 2025-10-28 · NCT03452774

A Study of IBI363 in Subjects with Advanced Solid Malignancies

Renkami dalyviai2 fazė
  • Fred Hutchinson Cancer Center, Seattle
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2024-12-19 · NCT06281678

Melanoma tyrimai kituose miestuose

Kiti tyrimai Seattle

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.